Cargando…

Aptamer-Dendrimer Bioconjugates for Targeted Delivery of miR-34a Expressing Plasmid and Antitumor Effects in Non-Small Cell Lung Cancer Cells

Metastasis and drug resistance are major barriers for the treatment of non-small cell lung cancer (NSCLC). To explore new therapeutic options, we successfully encapsulated MicroRNA-34a (miR-34a), a potent endogenous tumor suppressor in NSCLC into S6 aptamer-conjugated dendrimer to form lung cancer-t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Hongmei, Zhao, Xin, Guo, Caihong, Ren, Dunqiang, Zhao, Yandong, Xiao, Wei, Jiao, Wenjie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4583438/ https://www.ncbi.nlm.nih.gov/pubmed/26406332 http://dx.doi.org/10.1371/journal.pone.0139136

Ejemplares similares

Dendrimer– and polymeric nanoparticle–aptamer bioconjugates as nonviral delivery systems: a new approach in medicine
por: Mignani, Serge, et al.
Publicado: (2020)

Brain Delivery of Multifunctional Dendrimer Protein Bioconjugates
por: Moscariello, Pierpaolo, et al.
Publicado: (2018)

Bioconjugates of PAMAM dendrimers with trans-retinal, pyridoxal, and pyridoxal phosphate
por: Filipowicz, A, et al.
Publicado: (2012)

Novel Aptamer-Nanoparticle Bioconjugates Enhances Delivery of Anticancer Drug to MUC1-Positive Cancer Cells In Vitro
por: Yu, Chenchen, et al.
Publicado: (2011)

Aptamer-Functionalized Dendrimer Delivery of Plasmid-Encoding lncRNA MEG3 Enhances Gene Therapy in Castration-Resistant Prostate Cancer
por: Tai, Zongguang, et al.
Publicado: (2020)

Synthetically controlling dendrimer flexibility improves delivery of large plasmid DNA
por: Kretzmann, Jessica A., et al.
Publicado: (2017)

A ruthenium–oligonucleotide bioconjugated photosensitizing aptamer for cancer cell specific photodynamic therapy
por: McKenzie, Luke K., et al.
Publicado: (2021)

A Mixed-Surface Polyamidoamine Dendrimer for In Vitro and In Vivo Delivery of Large Plasmids
por: Srinageshwar, Bhairavi, et al.
Publicado: (2020)

Turning an Aptamer into a Light-Switch Probe with a Single Bioconjugation
por: Wickramaratne, Thakshila M., et al.
Publicado: (2014)

In vivo antitumor activity of liposome-plasmid DNA encoding mutant survivin-T34A in cervical cancer
por: Qiu, Fang, et al.
Publicado: (2018)

Codelivery of Genistein and miRNA-29b to A549 Cells Using Aptamer-Hybrid Nanoparticle Bioconjugates
por: Sacko, Koita, et al.
Publicado: (2019)

Second-Generation Polyamidoamine Dendrimer Conjugated with Oligopeptides Can Enhance Plasmid DNA Delivery In Vitro
por: Kim, Seongyeon, et al.
Publicado: (2023)

Pullulan Based Bioconjugates for Ocular Dexamethasone Delivery
por: Kicková, Eva, et al.
Publicado: (2021)

Dendrimers for Drug Delivery
por: Chauhan, Abhay Singh
Publicado: (2018)

A Controllable Aptamer-Based Self-Assembled DNA Dendrimer for High Affinity Targeting, Bioimaging and Drug Delivery
por: Zhang, Huimin, et al.
Publicado: (2015)

Aptamer-miR-34c Conjugate Affects Cell Proliferation of Non-Small-Cell Lung Cancer Cells
por: Russo, Valentina, et al.
Publicado: (2018)

Different patterns of nuclear and mitochondrial penetration by the G3 PAMAM dendrimer and its biotin–pyridoxal bioconjugate BC-PAMAM in normal and cancer cells in vitro
por: Uram, Łukasz, et al.
Publicado: (2015)

Clinical characteristics of patients with ROS1 gene rearrangement in non-small cell lung cancer: a meta-analysis
por: Bi, Huanhuan, et al.
Publicado: (2020)

Dendrimers for siRNA Delivery
por: Biswas, Swati, et al.
Publicado: (2013)

Dendrimers in drug delivery and targeting: Drug-dendrimer interactions and toxicity issues
por: Madaan, Kanika, et al.
Publicado: (2014)

Mechanistic investigations of antitumor activity of a Rhodamine B-oleanolic acid derivative bioconjugate
por: Macașoi, Ioana, et al.
Publicado: (2020)

Mechanistic investigations of antitumor activity of a Rhodamine B-oleanolic acid derivative bioconjugate
por: Macașoi, Ioana, et al.
Publicado: (2021)

The liver X receptor agonist T0901317 reduces the inflammation of alveolar epithelial cells induced by polyhexamethylene guanidine through inhibition of the NFκB signaling pathway
por: Wei, Lutang, et al.
Publicado: (2021)

Cell-Penetrating Peptide-Mediated Delivery of TALEN Proteins via Bioconjugation for Genome Engineering
por: Liu, Jia, et al.
Publicado: (2014)

Bioconjugated Carbon Dots for Delivery of siTnfα to Enhance Chondrogenesis of Mesenchymal Stem Cells by Suppression of Inflammation
por: Liu, Jianwei, et al.
Publicado: (2019)

Cancer Drug Delivery: Considerations in the Rational Design of Nanosized Bioconjugates
por: Kobayashi, Hisataka, et al.
Publicado: (2014)

Dynamic Core–Shell Bioconjugates for Targeted Protein Delivery and Release
por: Seidler, Christiane, et al.
Publicado: (2018)

Current Aspects of siRNA Bioconjugate for In Vitro and In Vivo Delivery
por: Tai, Wanyi
Publicado: (2019)

Recent Progress in Bioconjugation Strategies for Liposome-Mediated Drug Delivery
por: Almeida, Bethany, et al.
Publicado: (2020)

Biostable Double-Strand Circular Aptamers Conjugated Onto Dendrimers for Specific Capture and Inhibition of Circulating Leukemia Cells
por: Li, Yu, et al.
Publicado: (2021)

Dendrimer-conjugated isotretinoin for controlled transdermal drug delivery
por: Zhao, Tianqi, et al.
Publicado: (2023)

Enhanced In Vitro Antitumor Activity of GnRH-III-Daunorubicin Bioconjugates Influenced by Sequence Modification
por: Schuster, Sabine, et al.
Publicado: (2018)

Bromomaleimide-Linked Bioconjugates Are Cleavable in Mammalian Cells
por: Moody, Paul, et al.
Publicado: (2012)

The potential of dendrimer in delivery of therapeutics for dentistry
por: Bapat, Ranjeet A., et al.
Publicado: (2019)

UTMD-Promoted Co-Delivery of Gemcitabine and miR-21 Inhibitor by Dendrimer-Entrapped Gold Nanoparticles for Pancreatic Cancer Therapy
por: Lin, Lizhou, et al.
Publicado: (2018)

Polydopamine-Based Surface Modification of Novel Nanoparticle-Aptamer Bioconjugates for In Vivo Breast Cancer Targeting and Enhanced Therapeutic Effects
por: Tao, Wei, et al.
Publicado: (2016)

Aptamers Enhance Oncolytic Viruses’ Antitumor Efficacy
por: Dymova, Maya A., et al.
Publicado: (2022)

Aptamer-hybrid nanoparticle bioconjugate efficiently delivers miRNA-29b to non-small-cell lung cancer cells and inhibits growth by downregulating essential oncoproteins
por: Perepelyuk, Maryna, et al.
Publicado: (2016)

AS1411 Aptamer-Anionic Linear Globular Dendrimer G2-Iohexol Selective Nano-Theranostics
por: Mohammadzadeh, Pardis, et al.
Publicado: (2017)

Lung squamous cell carcinoma with rare epidermal growth factor receptor mutation G719X: a case report and literature review
por: Bi, Huanhuan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1fsd2jpaaidc140sp67ta9lq27